Trial intelligence / Profile preview

Eflornithine Hydrochloride Cream in African-American Men With Pseudofolliculitis Barbae

NCT00176995Phase 2Completed

Start
Mar 1999
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of eflornithine in pseudofolliculitis barbae (PFB). Primary endpoint: Observation of changes in actin filament/stress fibers orientation formation and location in the beard hair follicles. Started Mar 1999; status: completed.

02

Drugs

eflornithine
03

Conditions

pseudofolliculitis barbae (PFB)

Beyond the preview

Go deeper on NCT00176995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00176995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call